Combination of thalidomide, pegylated liposomal doxorubicin, dexamethasone and bortezomib (THADD-V) in relapsed/refractory Multiple Myeloma: results of a phase II study

Authors
Publication date
1 January 2009
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Bari

    redirect
    oaioai:ricerca.uniba.it:11586/103...
    Last time updated on 12/11/2016